NO20051018L - Farmasoytisk preparat inneholdende en benzimidazolforbindelse blandet med mikrokrystallinsk cellulose og en fremgangsmate for fremstilling derav - Google Patents

Farmasoytisk preparat inneholdende en benzimidazolforbindelse blandet med mikrokrystallinsk cellulose og en fremgangsmate for fremstilling derav

Info

Publication number
NO20051018L
NO20051018L NO20051018A NO20051018A NO20051018L NO 20051018 L NO20051018 L NO 20051018L NO 20051018 A NO20051018 A NO 20051018A NO 20051018 A NO20051018 A NO 20051018A NO 20051018 L NO20051018 L NO 20051018L
Authority
NO
Norway
Prior art keywords
microcrystalline cellulose
preparation
pharmaceutical composition
composition containing
benzimidazole compound
Prior art date
Application number
NO20051018A
Other languages
English (en)
Norwegian (no)
Inventor
Peter Kraass
Andrea Burgenmeister
Frank Muskulus
Original Assignee
Ratiopharm Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE10235475A external-priority patent/DE10235475B4/de
Application filed by Ratiopharm Gmbh filed Critical Ratiopharm Gmbh
Publication of NO20051018L publication Critical patent/NO20051018L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
NO20051018A 2002-08-02 2005-02-24 Farmasoytisk preparat inneholdende en benzimidazolforbindelse blandet med mikrokrystallinsk cellulose og en fremgangsmate for fremstilling derav NO20051018L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US40007102P 2002-08-02 2002-08-02
DE10235475A DE10235475B4 (de) 2002-08-02 2002-08-02 Arzneimittel mit einer Benzimidazolverbindung im Gemisch mit mikrokristalliner Cellulose und Verfahren zu deren Herstellung
PCT/EP2003/007741 WO2004014345A1 (en) 2002-08-02 2003-07-16 Pharmaceutical preparation containing a benzimidazole compound mixed with microcrystalline cellulose and a method for its preparation

Publications (1)

Publication Number Publication Date
NO20051018L true NO20051018L (no) 2005-02-24

Family

ID=31716591

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20051018A NO20051018L (no) 2002-08-02 2005-02-24 Farmasoytisk preparat inneholdende en benzimidazolforbindelse blandet med mikrokrystallinsk cellulose og en fremgangsmate for fremstilling derav

Country Status (15)

Country Link
US (1) US7732474B2 (de)
EP (1) EP1524967B1 (de)
JP (1) JP2005536527A (de)
AT (1) ATE388695T1 (de)
AU (1) AU2003244647B2 (de)
BR (1) BR0313173A (de)
CA (1) CA2494716A1 (de)
DE (1) DE60319707T2 (de)
ES (1) ES2299710T3 (de)
NO (1) NO20051018L (de)
PL (1) PL208130B1 (de)
PT (1) PT1524967E (de)
RU (1) RU2332237C2 (de)
WO (1) WO2004014345A1 (de)
ZA (1) ZA200500324B (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL130602A0 (en) 1999-06-22 2000-06-01 Dexcel Ltd Stable benzimidazole formulation
US20050214371A1 (en) * 2004-03-03 2005-09-29 Simona Di Capua Stable pharmaceutical composition comprising an acid labile drug
WO2006026829A1 (en) * 2004-09-09 2006-03-16 Metelli Pty Ltd Stable paste composition of enteric coated acid labile active agent and use thereof
EP1785135A1 (de) * 2005-11-10 2007-05-16 Laboratorios Del Dr. Esteve, S.A. Neue Lanzoprazol enthaltende stabilisierte galenische Formulierungen und ihre Herstellung
EP2026768B1 (de) * 2006-06-01 2018-02-28 Dexcel Pharma Technologies Ltd. Pharmazeutische formulierung auf mehreren einheiten
CN101500541B (zh) 2006-08-11 2011-06-15 旭化成化学株式会社 含有水难溶性药物的球状素颗粒的制造方法
RU2414889C2 (ru) * 2007-11-16 2011-03-27 Общество С Ограниченной Ответственностью "Технология Лекарств" Фармацевтическая композиция для лечения язвы желудка и двенадцатиперстной кишки в форме твердых желатиновых капсул, содержащая рабепразол или его производные, и способ ее получения
US8911787B2 (en) * 2008-02-26 2014-12-16 Ranbaxy Laboratories Limited Stable oral benzimidazole compositions and process of preparation thereof
EP2319504A1 (de) * 2009-11-07 2011-05-11 Laboratorios Del. Dr. Esteve, S.A. Feste pharmazeutische Dosierform
WO2012171540A1 (en) * 2011-06-15 2012-12-20 Bene-Arzneimittel Gmbh Suppository comprising pantoprazole comprised in pellets with a cellulose core
WO2016174664A1 (en) 2015-04-29 2016-11-03 Dexcel Pharma Technologies Ltd. Orally disintegrating compositions
WO2017061621A1 (ja) * 2015-10-07 2017-04-13 協和発酵キリン株式会社 アリールアルキルアミン化合物含有医薬組成物
JP6168673B2 (ja) 2015-10-07 2017-07-26 協和発酵キリン株式会社 アリールアルキルアミン化合物含有医薬組成物
WO2017145146A1 (en) 2016-02-25 2017-08-31 Dexcel Pharma Technologies Ltd. Compositions comprising proton pump inhibitors
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions
EP3292862A1 (de) 2016-09-07 2018-03-14 Sandoz Ag Omeprazolformulierungen

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2471186A1 (fr) * 1979-12-10 1981-06-19 Roussel Uclaf Nouveaux comprimes a delitescence colique, ainsi que leur procede de preparation
GB2189698A (en) * 1986-04-30 1987-11-04 Haessle Ab Coated omeprazole tablets
FR2692146B1 (fr) * 1992-06-16 1995-06-02 Ethypharm Sa Compositions stables de microgranules d'omeprazole gastro-protégés et leur procédé d'obtention.
JPH0733659A (ja) * 1992-07-17 1995-02-03 Yoshitomi Pharmaceut Ind Ltd 抗潰瘍剤含有製剤
SE9302395D0 (sv) * 1993-07-09 1993-07-09 Ab Astra New pharmaceutical formulation
MX9600857A (es) * 1994-07-08 1997-06-28 Astra Ab Forma de dosificacion i en tabletas, con unidades multiples.
ES2094694B1 (es) * 1995-02-01 1997-12-16 Esteve Quimica Sa Nueva formulacion farmaceuticamente estable de un compuesto de bencimidazol y su proceso de obtencion.
CH687810A5 (de) * 1995-05-24 1997-02-28 Mepha Ag Pelletformulierung mit Omeprazol.
US5824339A (en) * 1995-09-08 1998-10-20 Takeda Chemical Industries, Ltd Effervescent composition and its production
DE19626045C2 (de) 1996-06-28 1998-12-03 Klinge Co Chem Pharm Fab Stabile Arzneiform zur oralen Verabreichung, welche Omeprazol als aktiven Wirkstoff enthält, sowie Verfahren zur Herstellung derselben
SI0991407T2 (en) * 1997-03-13 2005-10-31 Hexal Ag Stabilization of acid sensitive benzimidazols with amino/cyclodextrin combinations
ES2137862B1 (es) * 1997-07-31 2000-09-16 Intexim S A Preparacion farmaceutica oral que comprende un compuesto de actividad antiulcerosa y procedimiento para su obtencion.
US6096340A (en) * 1997-11-14 2000-08-01 Andrx Pharmaceuticals, Inc. Omeprazole formulation
US6228400B1 (en) 1999-09-28 2001-05-08 Carlsbad Technology, Inc. Orally administered pharmaceutical formulations of benzimidazole derivatives and the method of preparing the same
DE19959419A1 (de) * 1999-12-09 2001-06-21 Ratiopharm Gmbh Stabile galenische Zubereitungen umfassend ein Benzimidazol und Verfahren zu ihrer Herstellung
EP1108425B1 (de) 1999-12-16 2005-06-08 Laboratorio Medinfar-Produtos Farmaceuticos, S.A. Neue stabile mehreinheitliche substituierte Benzimidazole enthaltende pharmazeutische Präparate

Also Published As

Publication number Publication date
US20050129760A1 (en) 2005-06-16
HK1072195A1 (en) 2005-08-19
AU2003244647A1 (en) 2004-02-25
JP2005536527A (ja) 2005-12-02
RU2005102814A (ru) 2005-12-20
RU2332237C2 (ru) 2008-08-27
PT1524967E (pt) 2008-04-03
CA2494716A1 (en) 2004-02-19
PL208130B1 (pl) 2011-03-31
DE60319707T2 (de) 2008-07-17
BR0313173A (pt) 2007-07-17
AU2003244647B2 (en) 2008-04-17
EP1524967B1 (de) 2008-03-12
PL374827A1 (en) 2005-10-31
US7732474B2 (en) 2010-06-08
DE60319707D1 (de) 2008-04-24
ES2299710T3 (es) 2008-06-01
ZA200500324B (en) 2006-07-26
WO2004014345A1 (en) 2004-02-19
ATE388695T1 (de) 2008-03-15
EP1524967A1 (de) 2005-04-27

Similar Documents

Publication Publication Date Title
NO20051018L (no) Farmasoytisk preparat inneholdende en benzimidazolforbindelse blandet med mikrokrystallinsk cellulose og en fremgangsmate for fremstilling derav
NO20043367L (no) Oralt farmasoytisk preparat
EE04911B1 (et) Ühend ja farmatseutiline kompositsioon proteaasi inhibiitoritena, nende kasutamine ning meetod selle ühendi valmistamiseks
JO2515B1 (en) Gamma-Crystalline form of ivabradine hydrochloride,a process for its preparation and pharmaceutical composition containing it
NO20070224L (no) 2-karbamid-4-fenyltiazolderivater, fremstilling og terapeutisk anvendelse derav
NO20050741L (no) Ny fremgangsmate for syntesen og ny krystallinsk form av agomelatin og farmasoytiske sammensetninger inneholdende den
NO20074823L (no) Rasagilin-formuleringer med forbedret innholdsensartethet
JO2984B1 (ar) تركيب الجسم المضاد her2
NO20062513L (no) Sammensetninger og doseringsformer for forsterket absorpsjon av metformin
EA200970585A1 (ru) Бензамидные производные как агонисты ер-рецепторов
UA97161C2 (ru) Фармацевтическая композиция, которая содержит дигидропиридиновый антагонист кальциевого канала лерканидипин и коллоидный диоксид кремния, способ ее приготовления
UA83720C2 (ru) Кристаллическая форма v агомелатина, способ ее получения и фармацевтическая композиция, которая ее содержит
TNSN07337A1 (en) Pharmaceutical composition comprising an indolylmaleimide derivative
IL164440A0 (en) New pharmaceutical composition containing fibanserin polymorph a
BRPI0413676A (pt) composto, e, composição farmacêutica
UA101407C2 (ru) Стабильная комбинированная фармацевтическая композиция амлодипина и бисопролола фумарат
MY143568A (en) 11b-hsd1 inhibitors for the treatment of diabetes
JO2749B1 (en) Indole-2-Wen derivatives bilaterally substituted at position 3, their preparation and therapeutic application
EA200800783A1 (ru) Композиция тразодона для введения один раз в день
MXPA05013758A (es) Composiciones farmaceuticas que incluyen una antihistamina y un estimulante y uso de las mismas.
BR0311970A (pt) Novos compostos, seu uso e preparação
ATE462703T1 (de) Bicyclononen-derivate als renin-inhibitoren
DK1631574T3 (da) Colchicosidanaloge
EA200700203A1 (ru) Фармацевтическая композиция, содержащая габапентин
RU2011143735A (ru) Средство для отбеливания кожи и косметический способ отбеливания кожи

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application